Enlivex Therapeutics Ltd. Quarterly Common Stock, Shares Authorized from Q4 2013 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Enlivex Therapeutics Ltd. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2013 to Q2 2024.
  • Enlivex Therapeutics Ltd. Common Stock, Shares Authorized for the quarter ending June 30, 2024 was 45M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 45M 0 0% Jun 30, 2024 6-K 2024-08-30
Q4 2023 45M 0 0% Dec 31, 2023 6-K 2024-08-30
Q2 2023 45M 0 0% Jun 30, 2023 6-K 2023-09-01
Q4 2022 45M 0 0% Dec 31, 2022 20-F 2024-04-30
Q2 2022 45M 0 0% Jun 30, 2022 6-K 2022-08-22
Q4 2021 45M 0 0% Dec 31, 2021 20-F 2023-04-10
Q2 2021 45M 0 0% Jun 30, 2021 6-K 2021-08-06
Q4 2020 45M 0 0% Dec 31, 2020 20-F 2022-04-29
Q2 2020 45M Jun 30, 2020 6-K/A 2020-10-13
Q4 2019 45M +33.1M +279% Dec 31, 2019 20-F 2021-04-30
Q4 2018 11.9M +10.6M +849% Dec 31, 2018 20-F 2020-04-30
Q4 2017 1.25M -8.75M -87.5% Dec 31, 2017 20-F/A 2020-01-23
Q4 2016 10M -40M -80% Dec 31, 2016 20-F 2018-04-23
Q4 2015 50M 0 0% Dec 31, 2015 20-F 2017-02-24
Q4 2014 50M +33.4M +201% Dec 31, 2014 20-F 2016-03-29
Q4 2013 16.6M Dec 31, 2013 20-F 2015-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.